Cribstone Capital Management, LLC Edwards Lifesciences Corp Transaction History

Cribstone Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $865 - $1,282	-10 Closed	0 $0
Q3 2021 Nov 18, 2021	SELL	$102.91 - $122.75 $59,687 - $71,195	-580 Reduced 98.31%	10 $1,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $49,465 - $61,808	590 New	590 $61,000
Q1 2019 Apr 11, 2019	SELL	$47.89 - $64.05 $3,256 - $4,355	-68 Closed	0 $0
Q1 2018 Apr 19, 2018	BUY	$37.19 - $47.45 $855 - $1,091	23 Added 51.11%	68 $9,000
Q3 2017 Oct 30, 2017	BUY	$36.29 - $38.83 $1,633 - $1,747	45	45 $5,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Cribstone Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cribstone Capital Management, LLC with notifications on news.